BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, November 28, 2024
See today's BioWorld
Home
» Dual Peptide Could ‘Transform’ Diabetes Treatment, Study Shows
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Dual Peptide Could ‘Transform’ Diabetes Treatment, Study Shows
Nov. 6, 2013
By
Sharon Kingman
No Comments
LONDON – A composite molecule that targets the two primary hormones that are released by the gut following meals can reduce weight and lower blood sugar in animal models, raising hopes of new and more effective treatments for obesity and diabetes.
BioWorld